Rapid Progression to Biologics Linked to Disease Severity in Very Early Onset IBD - MD Magazine

Overall, 61.8% of patients on their first biologic agent reported clinical remission.

Very early onset inflammatory bowel disease (IBD) with the associated biologic therapy is linked to an increased risk of Perianal fistulizing disease or structuring disease, but also a higher respons… [+3167 chars]

full article...